Latest Artificial pancreas Stories
Adventist Health System (AHS) announced today that they have signed an agreement with MD Scientific, LLC (Charlotte, NC) to make the EndoTool™ Glucose Management System the "standard of care" for controlling in-patient blood glucose levels throughout AHS's 36 hospital system. EndoTool™ is a highly sophisticated software system that calculates the dose of intravenous (IV) insulin needed to quickly control blood glucose levels in a critical care setting. It actively models...
NEW YORK (Reuters Health) - For patients with type 2 diabetes, control of blood sugar (glycemic control) does not appear to be improved if they self-monitor their blood glucose levels, according to researchers at the University of Western Australia, Fremantle. Dr. Wendy A. Davis and colleagues examined data from 1,286 patients enrolled in the Fremantle Diabetes Study. A total of 531 subjects completed annual reviews over five years. The results of the study are published in the...
By David Douglas NEW YORK (Reuters Health) - Continuous monitoring-guided insulin adjustment appears to be no more effective than intermittent fingerstick monitoring in achieving control of blood sugar, or blood "glucose," in certain children with type 1 diabetes, Australian researchers report in the journal Diabetes Care. Lead investigator Dr. Kylie Yates told Reuters Health that continuous glucose monitoring "can be a useful clinical tool, but in some populations similar improvement...
By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - A new device that monitors blood sugar constantly and lets the patient pump insulin right away if needed might greatly simplify life for people with diabetes, experts told a meeting on Monday. The Medtronic Inc. device combines an insulin pump and a continuous blood-monitoring system. It sounds an alarm if blood sugar goes out of safe ranges. Patients are clamoring to test and use the device, researchers for the...
By Megan Rauscher NEW YORK (Reuters Health) - For preschool-age children with type 1 diabetes, using a continuous subcutaneous pump to deliver insulin is a "safe, effective and superior" alternative to twice-daily insulin injections, according to a new study. Insulin pumps have been used successfully by adults, adolescents and school children, Dr. Tseghai Berhe from Loyola University Medical Center in Maywood, Illinois and colleagues note in their report, but pumps haven't been used...
NEW YORK (Reuters Health) - An 18-page booklet may help diabetics get a better handle on their blood sugar levels, according to researchers. The manual gives both practical advice on how to check blood sugar and interpret the test results, and how to emotionally deal with the difficulty of keeping blood sugar levels normal, Dr. Elaine C. Moreland of the University of Alabama, Birmingham, and colleagues explain in the Archives of Internal Medicine. Among 199 adults with type 1 or type...
NEW YORK (Reuters) - DexCom Inc. on Monday announced that U.S. regulators approved its glucose-monitoring system designed to diabetics manage their blood-sugar levels. DexCom said its STS Continuous Glucose Monitoring System consists of a tiny wire-like sensor that is inserted by the patient just under the skin. The sensor continuously measures glucose levels, which are transmitted wirelessly to a cell phone-like receiver, DexCom said. The receiver provides patients with real-time...
By Karla Gale NEW YORK (Reuters Health) - Researchers at Harvard Medical School have developed a protocol in mice in which insulin-producing islet cells are labeled with a magnetic imaging probe that can be detected by MRI, thus representing a potential easy noninvasive way for doctors to follow islet cell transplantation in humans. Islet cell transplantation is a promising therapy for insulin-dependent or type 1 diabetes. "Right now, all we can do to follow the fate of transplanted...
CHICAGO - Researchers are using a new cell transplantation technique to restore the cells that produce insulin in patients with type 1 diabetes. The method is minimally invasive, with few complications. The study was presented today at the annual meeting of the Radiological Society of North America (RSNA)."We used ultrasound guidance to inject donor cells into the portal vein of diabetic patients, which is accessed through the skin," said co-author Saravanan Krishnamoorthy, M.D.,...
La Jolla, CA "“ In many patients with type 2 diabetes, the liver acts like a sugar factory on overtime, churning out glucose throughout the day, even when blood sugar levels are high. Scientists at the Salk Institute for Biological Studies discovered a key cellular switch that controls glucose production in liver cells. This switch may be a potential new target for the development of highly specific diabetes drugs that signal the liver to reduce the production of sugar. The Salk...
